Novel anticoagulants in atrial fibrillation: focused update

Journal
e-Journal of Cardiology Practice
Date Issued
2013-07-15
Author(s)
Abstract
Novel oral anticoagulants are safer than Vitamin K antagonists (warfarin) in respect to the occurrence of bleeding, especially in terms of intracranial hemorrhage.
Furthermore they are non-inferior and to a certain degree are superior in comparison to warfarin, when it comes to the prevention of ischemic stroke in patients with atrial fibrillation (AF).
Subjects

atrial fibrillation

File(s)
Loading...
Thumbnail Image
Name

Novel anticoagulants in atrial fibrillation focused update.pdf

Size

114.5 KB

Format

Adobe PDF

Checksum

(MD5):f49893d0ee412f12115ef94bb7f9c9e2